Cyclin I-like (CCNI2) is a cyclin-dependent kinase 5 (CDK5) activator and is involved in cell cycle regulation (vol 7, 40979, 2017)

被引：3
|
作者：
Liu, Chengcheng
Zhai, Xiaoyan
Zhao, Bin
Wang, Yanfei
Xu, Zhigang
机构：
来源：
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词：
D O I：
10.1038/srep44164
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Scientific Reports 7: Article number: 40979; published online: 23 January 2017; updated: 15 March 2017 This Article contains errors in the Reference list. Reference 33 is incorrectly listed as reference 26 and references 26–32 are incorrectly listed as references 27–33 respectively. The correct references are listed below:
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Aberrant expression of cyclin-dependent kinase-5 (CDK5) in inclusion body myositis (IBM)
    Nakano, S
    Engel, AG
    Akiguchi, I
    Kimura, J
    NEUROLOGY, 1997, 48 (03) : 2109 - 2109
  • [32] p39, the Primary Activator for Cyclin-dependent Kinase 5 (Cdk5) in Oligodendroglia, Is Essential for Oligodendroglia Differentiation and Myelin Repair
    Bankston, Andrew N.
    Li, Wenqi
    Zhang, Hui
    Ku, Li
    Liu, Guanglu
    Papa, Filomena
    Zhao, Lixia
    Bibb, James A.
    Cambi, Franca
    Tiwari-Woodruff, Seema K.
    Feng, Yue
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (25) : 18047 - 18057
  • [33] Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35
    Amin, ND
    Albers, W
    Pant, HC
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 67 (03) : 354 - 362
  • [34] Prenatal cocaine and morphine alter brain cyclin-dependent kinase 5 (Cdk5) activity in rat pups
    Bhat, Rama
    Chari, Gopal
    Rao, Ravi
    Wirtshafter, David
    NEUROTOXICOLOGY AND TERATOLOGY, 2006, 28 (05) : 625 - 628
  • [35] Cyclin Dependent Kinase 5 (CDK5) Mediates T-Cell Activation and Immune Regulation in Aplastic Anemia
    Gupta, Ashish
    Wei, Hsi-Ju
    Kao, Wei-Ming
    Pareek, Tej
    Leterio, John
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S95 - S95
  • [36] Cyclin-dependent kinase 5 (Cdk5): A potential therapeutic target for the treatment of neurodegenerative diseases and diabetes mellitus
    Wei, Fan-Yan
    Tomizawa, Kazuhito
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (10) : 1070 - 1074
  • [37] Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation
    Zhu, YS
    Saito, T
    Asada, A
    Maekawa, S
    Hisanaga, S
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 (06) : 1535 - 1545
  • [38] p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway
    Patrick, GN
    Zhou, PB
    Kwon, YT
    Howley, PM
    Tsai, LH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) : 24057 - 24064
  • [39] Distinct cellular compartment of cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activator protein (p35(nck5a)) in the developing rat cerebellum
    Matsushita, M
    Tomizawa, K
    Lu, YF
    Moriwaki, A
    Tokuda, M
    Itano, T
    Wang, JH
    Hatase, O
    Matsui, H
    BRAIN RESEARCH, 1996, 734 (1-2) : 319 - 322
  • [40] The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism
    Clare, PM
    Poorman, RA
    Kelley, LC
    Watenpaugh, KD
    Bannow, CA
    Leach, KL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (51) : 48292 - 48299
12345